IndraLab

Statements

SCN4A inhibits VT/VF. 1 / 1

| 1

reach

"Whereas SkM1 gene transfer reduces the incidence of inducible VT/VF, Cx32 therapy to improve gap junctional conductance results in larger infarct size, a different VT morphology, and no antiarrhythmic efficacy."

22374989

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

SCN4A inhibits VT/VF. 1 / 1

INDRA sources:

Databases

Reading